Curaleaf Holdings Statistics

Total Valuation

TSX:CURA has a market cap or net worth of CAD 3.23 billion. The enterprise value is 4.62 billion.

Market Cap	3.23B
Enterprise Value	4.62B

Important Dates

The last earnings date was Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:CURA has 764.43 million shares outstanding. The number of shares has increased by 2.13% in one year.

Current Share Class	670.46M
Shares Outstanding	764.43M
Shares Change (YoY)	+2.13%
Shares Change (QoQ)	+1.66%
Owned by Insiders (%)	18.62%
Owned by Institutions (%)	3.26%
Float	616.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.84
PB Ratio	2.53
P/TBV Ratio	n/a
P/FCF Ratio	47.66
P/OCF Ratio	17.38
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.40, with an EV/FCF ratio of 68.12.

EV / Earnings	-12.09
EV / Sales	2.63
EV / EBITDA	11.40
EV / EBIT	n/a
EV / FCF	68.12

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 1.13.

Current Ratio	1.47
Quick Ratio	0.59
Debt / Equity	1.13
Debt / EBITDA	3.55
Debt / FCF	21.23
Interest Coverage	0.11

Financial Efficiency

Return on equity (ROE) is -21.69% and return on invested capital (ROIC) is 0.33%.

Return on Equity (ROE)	-21.69%
Return on Assets (ROA)	0.23%
Return on Invested Capital (ROIC)	0.33%
Return on Capital Employed (ROCE)	0.42%
Revenue Per Employee	317,825
Profits Per Employee	-69,288
Employee Count	5,519
Asset Turnover	0.43
Inventory Turnover	2.90

Taxes

In the past 12 months, TSX:CURA has paid 130.04 million in taxes.

Income Tax	130.04M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.25% in the last 52 weeks. The beta is 0.84, so TSX:CURA's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-3.25%
50-Day Moving Average	1.67
200-Day Moving Average	1.87
Relative Strength Index (RSI)	79.84
Average Volume (20 Days)	810,765

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CURA had revenue of CAD 1.75 billion and -382.40 million in losses. Loss per share was -0.51.

Revenue	1.75B
Gross Profit	853.24M
Operating Income	15.09M
Pretax Income	-172.04M
Net Income	-382.40M
EBITDA	326.84M
EBIT	15.09M
Loss Per Share	-0.51

Full Income Statement

Balance Sheet

The company has 139.48 million in cash and 1.44 billion in debt, giving a net cash position of -1.30 billion or -1.70 per share.

Cash & Cash Equivalents	139.48M
Total Debt	1.44B
Net Cash	-1.30B
Net Cash Per Share	-1.70
Equity (Book Value)	1.28B
Book Value Per Share	1.55
Working Capital	187.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 186.09 million and capital expenditures -118.24 million, giving a free cash flow of 67.85 million.

Operating Cash Flow	186.09M
Capital Expenditures	-118.24M
Free Cash Flow	67.85M
FCF Per Share	0.09

Full Cash Flow Statement

Margins

Gross margin is 48.64%, with operating and profit margins of 0.86% and -18.07%.

Gross Margin	48.64%
Operating Margin	0.86%
Pretax Margin	-9.81%
Profit Margin	-18.07%
EBITDA Margin	18.63%
EBIT Margin	0.86%
FCF Margin	3.87%

Dividends & Yields

TSX:CURA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.13%
Shareholder Yield	n/a
Earnings Yield	-11.83%
FCF Yield	2.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:CURA has an Altman Z-Score of 0.25 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.25
Piotroski F-Score	6